Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1801]
News [2700]
Articles [198]
Editorials [1]
Conferences [135]
elearning [13]
Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR...
Dr Thierry André - Sorbonne Université, Paris, France
Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC ( Dr Thierry André - Sorbonne Université, Paris, France )
24 Jan 2024
The evolving paradigm in management of Multiple Myeloma
Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
The evolving paradigm in management of Multiple Myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )
11 Dec 2023
Low-dose olanzapine after highly emetogenic chemotherapy can be the new...
Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India
Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours ( Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India )
7 Dec 2023
Cancer care in Needle Hospital, Hargeisa, Somaliland
Gebrekirstos Hagos - Needle Hospital, Hargeisa, Somaliland
Cancer care in Needle Hospital, Hargeisa, Somaliland ( Gebrekirstos Hagos - Needle Hospital, Hargeisa, Somaliland )
5 Dec 2023
Relapsed refractory multiple myeloma
Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
Relapsed refractory multiple myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )
5 Dec 2023
The evolving paradigm in management of Multiple Myeloma
D Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
The evolving paradigm in management of Multiple Myeloma ( D Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )
5 Dec 2023
Haemato-oncological Cancers
Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India
Haemato-oncological Cancers ( Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India )
16 Nov 2023
Multiple myeloma (A cancer arising from plasma cells)
Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal
Multiple myeloma (A cancer arising from plasma cells) ( Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal )
9 Nov 2023
Multiple myeloma (A cancer arising from plasma cells)
Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal
Multiple myeloma (A cancer arising from plasma cells) ( Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal )
9 Nov 2023
Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for...
Prof Ignace Vergote - UZ Leuven, Leuven, Belgium
Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer ( Prof Ignace Vergote - UZ Leuven, Leuven, Belgium )
7 Nov 2023
Pembrolizumab plus chemoradiotherapy shows clinically meaningful improvement in...
Prof Domenica Lorusso - Fondazione IRCCS National Cancer Institute, Milan, Italy
Pembrolizumab plus chemoradiotherapy shows clinically meaningful improvement in PFS for locally advanced cervical cancer ( Prof Domenica Lorusso - Fondazione IRCCS National Cancer Institute, Milan, Italy )
7 Nov 2023
Gynaecological Cancers
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Gynaecological Cancers ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
7 Nov 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation